We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.07B
1-Year Est. Return 34.24%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.24%
3 Year Est. Return
+104.05%
5 Year Est. Return
+133.06%
10 Year Est. Return
+500.1%
AUM
$2.84B
AUM Growth
+$220M
Cap. Flow
-$110M
Cap. Flow %
-3.88%
Top 10 Hldgs %
60.03%
Holding
67
New
27
Increased
4
Reduced
9
Closed
14

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$47.1M
2
DOV icon
Dover
DOV
+$36.2M
3
VOD icon
Vodafone
VOD
+$32.8M
4
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$28.1M
5
B
Barrick Mining
B
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 12.59%
2 Energy 8.49%
3 Materials 4.28%
4 Communication Services 4.21%
5 Financials 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOD icon
51
Vodafone
VOD
$37.2B
-892,268
Closed -$32.8M
VZ icon
52
Verizon
VZ
$193B
-4,851
Closed -$231K
XLV icon
53
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
-189,000
Closed -$11.1M
XLV icon
54
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
-4,000,000
Closed -$234M
DISCK
55
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-729,196
Closed -$28.1M
NGHC
56
DELISTED
National General Holdings Corp
NGHC
-955,000
Closed -$13.4M
HAWK
57
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
-125,000
Closed -$3.05M

Similar funds

Empyrean Capital Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Empyrean Capital Partners held 67 positions worth $2.84B, up 8.4% from $2.62B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Empyrean Capital Partners withdrew a net $110M in Q2 2014, closing 14 positions and reducing 9 holdings. Its most notable exit was Visa, an estimated $47.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 3.9% a quarter earlier, followed by Energy and Materials.

Against the trend, Empyrean Capital Partners opened a new position in Allergan Inc worth $84.6M.

  • Empyrean Capital Partners's largest Q2 2014 buy was Allergan Inc: 500,000 shares worth $84.6M.
  • Empyrean Capital Partners added most to UnitedHealth in Q2 2014, an estimated $46M increase.
  • Empyrean Capital Partners's biggest Q2 2014 reduction was Liberty Media Series A, cutting an estimated $10.3M.
  • Empyrean Capital Partners fully exited Visa in Q2 2014, selling an estimated $47.1M.
  • Empyrean Capital Partners's ten largest holdings make up 60% of its $2.84B portfolio in Q2 2014.
  • Empyrean Capital Partners opened 27 new positions and closed 14 in Q2 2014.
  • Empyrean Capital Partners's portfolio value rose 8.4% quarter-over-quarter to $2.84B.

Based on Empyrean Capital Partners's 13F filing for Q2 2014, filed 14 Aug 2014.